Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Identifying Factors Associated With Treatment Response in Rheumatoid Arthritis Clinical Trials

ACR Open Rheumatology(2022)10.1002/acr2.11468Source: DataRank Database

Identifying Factors Associated With Treatment Response in Rheumatoid Arthritis Clinical Trials is a research paper published in ACR Open Rheumatology (2022). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 1.23)OA: goldTopics (19)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Marianna Olave ORCID,Michael George ORCID,Joshua F. Baker ORCID,Anthony J. Cordisco ORCID

Live enrichment

PubMed:35770613 PMC:PMC9469477 OpenAlex:https://openalex.org/W4283739725

VA Rehabilitation Research & Development

Grant: CX003157

NIH HHS

Grant: K23AR073931

VA Rehabilitation Research & Development

Grant: CX003644

U.S. Department of Veterans Affairs

Grant: CX001703

National Institutes of Health

Grant: 5K23AR073931-04

Risk and impact of infection resulting from treatment with chronic glucocorticoids in patients with rheumatoid arthritis

GlaxoSmithKline Japan

GSK

Rheumatology Research Foundation

FWCI

1.23

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1002/acr2.11468

publisherhttps://doi.org/10.1002/acr2.11468

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35770613

repositoryhttps://doaj.org/article/0e256152874d494eb2ec150a911bbd97

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9469477

Fields of Study

Rheumatoid Arthritis Research and TherapiesBiosimilars and Bioanalytical MethodsSpondyloarthritis Studies and Treatments03 medical and health sciences0302 clinical medicine

Keywords

MedicineRheumatoid arthritisInternal medicineErythrocyte sedimentation rateAdalimumabRheumatologyClinical trialMethotrexateTofacitinibRandomized controlled trialPhysical therapyRC925-935Original ArticleDiseases of the musculoskeletal system

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being